Lai Wang

President, Global Head of R&D

Lai Wang (President, Global Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $357K of ONC (1,327 sh × $269.34, as filed), executed Jun 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Jun 23

Filed Jun 25

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ONC

BeOne Medicines AG ONC · 0 buys · 10 sells 10 filings BGNE BGNE BGNE · 0 buys · 2 sells 2 filings

Recent filings

ONCSALE BeOne Medicines AG View filing → $296K
1,068 sh × $276.74
Exec Jun 23
Filed Jun 25 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $310K
1,169 sh × $265.39
Exec Jun 16
Filed Jun 18 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $197K
756 sh × $261.00
Exec Jun 11
Filed Jun 15 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $357K
1,327 sh × $269.34
Exec Jun 8
Filed Jun 10 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $1.8M
5,000 sh × $350.06
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $1.1M
3,749 sh across 2 lots
Exec Jul 29 2025
Filed Jul 31 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $210K
700 sh × $300.00
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $267K
1,028 sh × $260.00
Exec Jun 23 2025
Filed Jun 25 2025 · 5:30 PM ET More filings →